Publicacions en col·laboració amb investigadors/es de Universidad de Castilla-La Mancha (10)

2023

  1. Effectiveness and safety of fluocinolone acetonide intravitreal implant in diabetic macular edema patients considered insufficiently responsive to available therapies (REACT): a prospective, non-randomized, and multicenter study

    International Ophthalmology, Vol. 43, Núm. 12, pp. 4639-4649

2020

  1. A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study

    PharmacoEconomics - Open, Vol. 4, Núm. 4, pp. 615-624

  2. Genetic and environmental factors related to the development of myopic maculopathy in Spanish patients

    PloS one, Vol. 15, Núm. 7, pp. e0236071

2019

  1. Myopic maculopathy: Current status and proposal for a new classification and grading system (ATN)

    Progress in Retinal and Eye Research, Vol. 69, pp. 80-115

2018

  1. Clinical decision-making when treating diabetic macular edema patients with dexamethasone intravitreal implants

    Ophthalmologica, Vol. 240, Núm. 2, pp. 61-72

2017

  1. Early and intermediate age-related macular degeneration: Update and clinical review

    Clinical Interventions in Aging, Vol. 12, pp. 1579-1587

2016

  1. Evaluation of 10 AMD Associated polymorphisms as a cause of choroidal neovascularization in highly myopic eyes

    PLoS ONE, Vol. 11, Núm. 9

2015

  1. Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to pathologic myopia six years outcome

    Retina, Vol. 35, Núm. 12, pp. 2450-2456

  2. Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept

    Drugs and Aging, Vol. 32, Núm. 10, pp. 797-807

2010

  1. Prevalence and causes of bilateral blindness and visual impairment among institutionalized elderly people in Pamplona, Spain

    European Journal of Ophthalmology, Vol. 20, Núm. 2, pp. 442-450